DWHP, Linden acquire aesthetic products maker Edge Systems


Edge Systems' premier system is the HydraFacial MD® serum-based hydradermabrasion system, ranked one level above IPL for skin rejuvenation. HydraFacial, HydraFacial MD, HydroPeel, UV Smart, Britenol, and Vortex Fusion are registered trademarks of Edge Systems LLC. Vortex Exlfoliation, Vortex Peel, Vortex Extraction, Vortex Boost, Daily Essentials, Edge For Life, Skin Health for Life, Ativ-4, Beta-HD, GlySal, Antiox+, amd Dermabuilder are trademarks of Edge Stystems LLC.

Healthcare private equity firms DW Healthcare Partners (DWHP) and Linden Capital Partners have jointly acquired Edge Systems LLC, a U.S. maker of non-invasive equipment and consumables used in aesthetic skin health treatments. No financial terms were released. Founded in 1997, Signal Hill, California’s Edge has an installed base of over 7,000 systems placed with dermatologists, plastic surgeons, and medical spas across 75 countries. With the deal, Clint Carnell and Steve Fanning will be named CEO and chairman of Edge, respectively. DWHP has offices in Toronto and Park City, Utah.

PRESS RELEASE

DW Healthcare Partners and Linden Capital Partners Announce Acquisition of Edge Systems

TORONTO, Dec. 5, 2016 /CNW/ — DW Healthcare Partners (“DWHP”) and Linden Capital Partners (“Linden”), both healthcare-focused private equity firms, announced today the joint acquisition of Edge Systems (“Edge” or the “Company”). Headquartered in Signal Hill, California, Edge is a leading manufacturer and marketer of non-invasive equipment and consumables used in aesthetic skin health treatments. Edge’s leading product is the HydraFacial™ line of facial skin rejuvenation devices, which provide a non-invasive, multistep treatment in one sitting that delivers results without downtime or irritation. Edge has a current installed base of over 7,000 systems placed with dermatologists, plastic surgeons, and medical spas across 75 countries.

As part of an aesthetics sector effort, Linden and DWHP teamed up with Clint Carnell and Steve Fanning, who will be named CEO and Chairman of Edge, respectively. Mr. Carnell is a 25-year medical device and aesthetics veteran who previously held leadership positions at Solta Medical, Covidien and Bausch & Lomb. Mr. Fanning has an extensive background in healthcare, aesthetics, and consumer pharmaceuticals. Currently CEO of Z-Medica, Mr. Fanning has also served as CEO of Solta Medical, CEO of Ocular Sciences, and held various senior leadership positions at Johnson & Johnson. Both executives were instrumental in canvassing the aesthetic skin health sector and leading diligence of Edge Systems.

“Edge is recognized as a pioneer in non-invasive aesthetic treatments, and we are excited by the continued growth potential of this business,” said Mr. Fanning. “With a unique technology and strong track record of customer and end-user satisfaction, Edge is well-positioned to address the growing demand for non-invasive facial rejuvenation treatments.”

Other key advisors joining the Edge Systems Board of Directors include Howard Kelly, former CEO of Alma Lasers, and Glenn Novotny, the previous Chairman of Edge Systems who oversaw its strong growth to date. Edge will also receive the continued support of Bill Cohen and Roger Ignon, who co-founded Edge and drove the Company’s success to date.

About DW Healthcare Partners

DW Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. The firm manages over $750 million in committed capital and invests in profitable healthcare companies with proven management teams.

DW Healthcare Partners is led by seasoned healthcare executives with more than 110 years of combined industry experience. The firm provides the capital, strategic guidance, and acquisition expertise to help mid-to-late-stage companies realize their potential for growth.

About Linden Capital Partners

Linden Capital Partners is a Chicago-based private equity group focused exclusively on leveraged investments in middle market healthcare and life science companies.

Over the past decade, they have grown to become one of the leading healthcare private equity investors by creating exceptional value for companies, business owners and investors. As a team, they have invested more than $1 billion in healthcare and life science companies, helping to build strong platforms and thriving businesses. Today, they manage $1.3 billion in assets augmented by capital provided by our Limited Partners for larger transactions.

For more information, please call DW Healthcare Partners at 416-583-2420.

Photo courtesy of Edge Systems LLC